Is MNKD Worth Buying in 2026?

Mannkind Corporation

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether Mannkind Corporation (MNKD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-15.29% over 10 days); RSI 86 — overbought, elevated pullback risk; weak 1-year return of -37.3%; 3-month momentum negative (-45.5%). Currently 56.4% off its 52-week high. Score: -7/7.

Ready to act on this? 📈 Trade on Webull

MNKD is trading below its 200-day MA ($4.67) — a key warning sign the longer-term trend is under pressure. With an RSI of 85.9, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -37.3% compares to +35.1% for SPY (trailed the market by 72.4%). The current 56.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $6,269 today
vs. S&P 500 (SPY) — same period trailed market by 72.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($4.67)
Above 50-day MA ($3.45)
!RSI(14) neutral zone (30–70) — currently 85.9
Positive return (-37.3%)
!Within 10% of period high (−56.4%)
Period Range $2.84
$2.23 $6.51
RSI (14) 85.9
0 · OversoldOverbought · 100

Key Metrics

Price$2.84
Period Return-37.3%
Period High$6.51
Period Low$2.23
Drawdown−56.4%
MA-50$3.45
MA-200$4.67
RSI (14)85.9
Avg Volume (30d)5.5M
vs. SPYtrailed by 72.4%
Return Rank#887 of 996

Trade MNKD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers